Results for “”

Entry Author Date Location
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device 02/19/20 Boston
Xcelerating Life Sciences Boston Will Explore Biopharma’s Future in Digital Health 02/19/20 Boston
ResTORbio Pins “Strategic Alternatives” Pitch to Parkinson’s Promise 02/19/20 Boston
Xcelerating Life Sciences Boston 02/18/20 Boston
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic 02/18/20 Boston
Voyager Therapeutics Chief Operating Officer Matthew Ottmer Resigns 02/14/20 Boston
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks 02/13/20 National
Anika Therapeutics Appoints Cheryl Blanchard Interim CEO 02/13/20 Boston
Palleon Pharma Promotes Li Peng to Chief Scientific Officer 02/13/20 Boston
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Lyndra Taps Pacira’s Richard Stanton for Chief Medical Officer Role 02/11/20 Boston
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts 02/10/20 Boston
Wave Life Sciences’ Stumble in Duchenne Leads to 22% Staff Layoff 02/10/20 Boston
Eli Lilly, Roche Drugs Fail to Move Needle in Genetically Driven Alzheimer’s 02/10/20 National
Takeda’s Peng Lu Joins Pharvaris as Chief Medical Officer 02/07/20 Boston
Bio Roundup: POTUS on Prices, a16z’s Fund, Aimmune’s Approval & More 02/07/20 National
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered 02/06/20 Boston
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Amylyx Pharmaceuticals Names Jeffrey Trigilio Chief Financial Officer 02/04/20 Boston
Boston Pharmaceuticals Picks NIBR’s Basson for Chief Medical Officer 02/03/20 Boston
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy 01/31/20 San Francisco
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Moderna Adds Takeda’s Melanie Ivarsson as Chief Development Officer 01/30/20 Boston
Disc Medicine Adds Longtime Acceleron Pharma Exec as New CEO 01/30/20 Boston
BIO Report: More Work Needed to Improve Diversity at Biotech Firms 01/30/20 National
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14 01/30/20 San Francisco
Black Diamond’s Upsized IPO Raises $201M to Advance Its Cancer Drug R&D 01/30/20 Boston
Page 1 of 664 next page »